Filter Results:
(312)
Show Results For
- All HBS Web
(312)
- People (1)
- News (124)
- Research (147)
- Multimedia (13)
- Faculty Publications (94)
Show Results For
- All HBS Web
(312)
- People (1)
- News (124)
- Research (147)
- Multimedia (13)
- Faculty Publications (94)
- 15 Jun 2021
- News
June 2021 Books and Podcasts
nations, people, and businesses. In COVID-19: Mankind’s Bitter Battle, Aneja makes practical suggestions about how to vaccinate the citizens of any country within 100 days of the vaccine becoming available;... View Details
- 15 May 2020
- Research & Ideas
Find Your Pragmatic Path through Radical Uncertainty
virus will give us the answers.” Will contracting the disease provide immunity? How long will immunity last? When will a successful vaccine be widely available? What will be an acceptable vaccine trial? How... View Details
- 01 Mar 2012
- News
How to Close the Health Gap
where innovation is winning the day. An increasing number of biotech start-ups are setting up shop in developing countries, and VC firms are chasing them. In Hyderabad, India, for example, Shantha Biotechnics created clever culture-growing techniques that dropped the... View Details
- 12 Jul 2021
- News
Alumni Confront the COVID-19 Crisis
all citizens of our country have access to healthcare and other necessities of life.” MAY 2 Garuda Aerospace, led by CEO Agnishwar Jayaprakash (PLDA 25, 2018), is employing his company’s drones to deliver vaccines and medical supplies.... View Details
- 01 Oct 2021
- News
New Biotech Joint Degree Program Kicks Off
addressing the pandemic in real time, including John Markels, president of global vaccines at Merck, and Dan Barouch, MD, an innovator in the field of infectious disease research at Beth Israel Deaconess Medical Center. Students were... View Details
- 02 Dec 2019
- News
Supporting the School as a Student and Young Alumna
when she was confined to a wheelchair for long periods—first as a little girl, then as a teen—due to hip problems brought on by a contaminated vaccine she received. “I especially loved watching behind-the-scenes shows about how a director... View Details
- 20 May 2016
- Op-Ed
World Health Organization Lacks Leadership to Combat Pandemics
greater role in WHO governance and if there are guarantees of purchase contracts for new drugs and vaccines at sensible prices. Both seem unlikely, as the WHO's culture has always winced at cooperation with the private sector. WHO's track... View Details
- 10 Mar 2021
- News
Action Plan: Brewing Awareness
rental expenses to preserve jobs. Now, as India begins a massive vaccination program, Murad is glad to have made it through the worst of the pandemic with White Owl’s workforce of 120 employees largely intact. “It’s easy to abandon ship... View Details
- 14 Jan 2022
- Blog Post
Embracing Activism for Social Change
vaccine rollout. More recently, she has been working on rental assistance with the housing department and helping to set up the deployment of Detroit’s $28 million share from the American Rescue Plan. Although the fellowship grant that... View Details
- 17 Feb 2021
- Research & Ideas
Pandemic Self-Care for CEOs: Rituals, Running, and Cognitive Restructuring
which a successful vaccine was developed; and the inherent sense of rebirth and freedom that comes with spring blend into a potent psychological cocktail. All of these things are, of course, legitimate cause for celebration and... View Details
- 01 Dec 2022
- News
December 2022 Alumni and Faculty Books and Podcasts
caregiving, and the hearts of caregivers. The Long Shot: The Inside Story of the Race to Vaccinate Britain By Kate E. Bingham (MBA 1991) and Tim Hames Oneworld Publications As chair of the UK’s task force charged with developing an... View Details
- 01 Jun 2009
- Lessons from the Classroom
The Challenges of Investing in Science-Based Innovation
she adds, with the development of a vaccine against cervical cancer (Gardasil) and the launch of successful new drugs to combat diabetes and HIV/AIDS. Sato acknowledges that different situations will require different business... View Details
- 17 Dec 2020
- Research & Ideas
The 10 Most Popular Stories of 2020
reader interest in an interview with Merck CEO Ken Frazier, who talked candidly about prospects for COVID-19 vaccines and racism in the workplace. Here are our most popular articles, research papers, and social media posts of 2020. In the... View Details
Keywords: by Dina Gerdeman
- 12 Dec 2022
- Research & Ideas
Buy-In from Black Patients Suffers When Drug Trials Don’t Include Them
Moderna, a pharmaceutical company, announced in September 2020 that it would slow enrollment of its COVID-19 vaccine trials to better improve representation. The majority of study participants were white, although COVID-19 was... View Details
- 22 Feb 2022
- News
Q&A: The Post-Pandemic Path
What prevented the crisis that the data in the spring and summer of 2020 predicted? There are three possible explanations. First, the crisis was much shorter and milder than we originally anticipated because the vaccines came out. Second,... View Details
Keywords: April White
- 25 Mar 2021
- News
Alumni Honor Nitin Nohria and Support His Legacy
looks at how the company built a digital organization that leverages AI and other technologies to speed its operations, manage its processes, and ensure quality across research, testing, and manufacturing in its race to develop a vaccine... View Details
- 01 Mar 2019
- News
The Blue-Green Revolution
biofuels project should eventually permit researchers to turn algae into microscopic factories for the manufacture of virtually any organic compound, leading to what Enriquez describes as a full-blown algal revolution. “You can make View Details
- 01 Jan 2002
- News
Raymond V. Gilmartin (MBA '68)
people provided important lessons for the battle against HIV/AIDS, says Gilmartin. Not only is Merck pursuing a safe and effective vaccine to prevent and treat HIV infection, he points out, but the company also announced last year that it... View Details
- 20 Apr 2020
- News
To Build Connection in Quarantine, Clubs Go Virtual
may not guarantee long-lasting immunity. This is of major importance for vaccine development, because a person must produce a sufficient amount of neutralizing antibodies to be protected.” Seftel has used the weekly updates to give a... View Details
Keywords: Margie Kelley
- 07 Aug 2012
- First Look
First Look: August 7
case:http://hbr.org/search/812158-PDF-ENG GlaxoSmithKline in Brazil: Public-Private Vaccine Partnerships Arthur A. Daemmrich and Ian McKown CornellHarvard Business School Case 712-049 Three years into a major public-private partnership... View Details
Keywords: Sean Silverthorne